Abstract 2: First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2055-0464
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Abstract 2: First-phase ejection fraction is a powerful predictor of adverse events in asymptomatic patients with aortic stenosis and preserved total ejection fraction ; volume:7 ; number:4 ; day:1 ; month:12 ; year:2020 ; pages:M7-M8 ; date:12.2020
Echo Research and Practice ; 7, Heft 4 (1.12.2020), M7-M8, 12.2020
- Creator
-
Gu, H.
Saeed, S.
Boguslavskyi, A.
Carr-White, G.
Chambers, J.
Chowienczyk, P.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/BF03651754
- URN
-
urn:nbn:de:101:1-2022061719455294409828
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:36 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Gu, H.
- Saeed, S.
- Boguslavskyi, A.
- Carr-White, G.
- Chambers, J.
- Chowienczyk, P.
- SpringerLink (Online service)
Other Objects (12)
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Right ventricular ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Right ventricular ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment
Endostatin a Potential Biomarker for Heart Failure with Preserved Ejection Fraction
Left atrial ejection fraction and outcomes in heart failure with preserved ejection fraction
Biomarkers in heart failure with preserved ejection fraction
Comorbidities in heart failure with preserved ejection fraction
Right ventricular ejection fraction
Animal models of heart failure with preserved ejection fraction
Heart Failure with Preserved Ejection Fraction—a Concise Review
133 Obesity is associated with decreased myocardial contraction fraction despite preserved ejection fraction
Gender-related differences in heart failure with preserved ejection fraction
Epicardial Adipose Tissue Thickness and Preserved Ejection Fraction Heart Failure
Dynamic trajectories of left ventricular ejection fraction in heart failure with improved ejection fraction
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment